Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in the treatment of myocardial infarction - Califf, R M; Topol, E J; George, B S; Boswick, J M; Sigmon, K W; Candela, R; Masek, R; O’Neill, W W; Stack, R S; Stumo, D (Am J Med, 1988)